Confo Therapeutics

Associate Director Business Development

Business Development Manager

Phoreon - a Brand of Pharma Diagnostics NV

Business Developer

Team Leader R&D

Senior Scientist R&D

PharmaDiagnostics focuses on the development and commercialising of label-free screenings for biomolecular interactions using localised surface plasmon resonance (LSPR) based nanotechnology.

Scientist

APO-SYS Scientist at the EU 7th Framework Programme. Main goal is to integrate experimental biology, data mining, mathematical modeling, biostatistics, system engineering and molecular medicine.

postdoctoral fellow

Group of Molecular Signaling and Cell death (groupleader Prof. Dr. P. Vandenabeele) in the VIB Department of Molecular Biomedical research (DMBR) headed by Prof. Dr. F. Van Roy. DMBR is now called Inflammation Reseach Center (VIB-IRC).

Successful grants as first author and first co-author to fund own research project and that of the host lab (785k€):
10k€ for testing a new emerging technology for genome editing (VIB)
375k€ to attract new personnel (IWT+FWO)
400k€ to develop biosensors to study necroptosis signalling pathways in live cells (FWO)

Group of Proteomics and Bioinformatics (groupleader Prof. Dr. K. Gevaert), in the VIB Department of Medical Protein chemistry (headed by Prof. Dr. J. Vandekerchove).

Group of Molecular and Metabolic Signaling, VIB Department of Medical Protein Chemistry (headed by Prof. Dr. J. Vandekerchove).

PhD thesis: 'Role of glyoxalase and its substrate methylglyoxal in TNF-induced necrotic cell death'

PhD-student

Ghent University

Lab. technician

Skilled in cell biology, biochemistry, biotechnology and drug discovery. Started originally as a lab technician, and obtained later on his master's degree in biotechnology and PhD in biomedical sciences at Ghent University (UGENT) and the Flemish Institute for Biotechnology (VIB).
Ideation to make-it-happen-for-real gives Franky goose bumps. 
Intra/Entrepreneurship is the driver. All the time, every time.

Happy to meet & discuss our obesity & endocrine programs, and technology to discover small molecules & biologics on class A, B and orphan GPCRs. Reach out via the Bio platform, LinkedIn or email.

Taplio

Franky Van Herreweghe's Linkedin Analytics

Franky Van Herreweghe

Performance ScoreFranky Van Herreweghe's LinkedIn Performance

Franky Van Herreweghe's Best Posts (last 30 days)

Ready to grow your LinkedIn presence?

Taplio

.css-6ytdur{background-image:linear-gradient(284deg, rgba(39, 43, 72, 1) 0%, rgba(33, 47, 183, 1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Franky Van Herreweghe's Linkedin Analytics

Franky Van Herreweghe

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}Franky Van Herreweghe's LinkedIn Performance

Franky Van Herreweghe's Best Posts .css-1emoo84{font-size:var(--chakra-fontSizes-md);font-weight:400;color:var(--chakra-colors-gray-600);}(last 30 days)

Ready to grow your LinkedIn presence?

Franky Van Herreweghe's Linkedin Analytics

Performance ScoreFranky Van Herreweghe's LinkedIn Performance

Franky Van Herreweghe's Best Posts (last 30 days)